Medication Discrepancy Risk Factors for Pediatric Patients With Epilepsy at Hospital Admission.

anticonvulsants epilepsy medication discrepancy medication history patient safety pediatrics quality improvement

Journal

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG
ISSN: 1551-6776
Titre abrégé: J Pediatr Pharmacol Ther
Pays: United States
ID NLM: 101089851

Informations de publication

Date de publication:
2021
Historique:
received: 29 06 2020
accepted: 22 09 2020
entrez: 26 5 2021
pubmed: 27 5 2021
medline: 27 5 2021
Statut: ppublish

Résumé

Children with epilepsy are at increased risk of medication errors due to disease complexity and administration of time-sensitive medication. Errors frequently occur during transitions of care between home and hospital, a time when accuracy of medication history lists is difficult to ascertain. Adverse events likely from medication discrepancies underscore the importance of improving medication reconciliation upon inpatient intake. This quality improvement project was designed to evaluate and optimize the current medication history process in epileptic patients upon hospital admission at a pediatric academic hospital. A retrospective chart review was conducted on 30 patients with epilepsy admitted in during April, July, and October 2018 to identify unintentional medication discrepancies among 6 sources: documented medication history, inpatient orders from the electronic medical record, outpatient clinic notes, inpatient history and admission document, phone message records, and external insurance claims. A total of 63% percent of patients had at least 1 unintentional medication discrepancy. Most discrepancies occurred with daily maintenance anticonvulsants (63%). The most common types were omission of medication history (31%) and inpatient order omissions (27%). The number of medication histories completed with at least 1 discrepancy varied across pharmacists, nurses, and physicians, yet differences were not statistically significant. Our study found a higher incidence of anticonvulsant discrepancies compared with previous studies. This quality improvement initiative identified the absence of a standardized process as the root cause for the high incidence of anticonvulsant discrepancies in pediatric patients with epilepsy at hospital admission.

Sections du résumé

BACKGROUND BACKGROUND
Children with epilepsy are at increased risk of medication errors due to disease complexity and administration of time-sensitive medication. Errors frequently occur during transitions of care between home and hospital, a time when accuracy of medication history lists is difficult to ascertain. Adverse events likely from medication discrepancies underscore the importance of improving medication reconciliation upon inpatient intake. This quality improvement project was designed to evaluate and optimize the current medication history process in epileptic patients upon hospital admission at a pediatric academic hospital.
METHODS METHODS
A retrospective chart review was conducted on 30 patients with epilepsy admitted in during April, July, and October 2018 to identify unintentional medication discrepancies among 6 sources: documented medication history, inpatient orders from the electronic medical record, outpatient clinic notes, inpatient history and admission document, phone message records, and external insurance claims.
RESULTS RESULTS
A total of 63% percent of patients had at least 1 unintentional medication discrepancy. Most discrepancies occurred with daily maintenance anticonvulsants (63%). The most common types were omission of medication history (31%) and inpatient order omissions (27%). The number of medication histories completed with at least 1 discrepancy varied across pharmacists, nurses, and physicians, yet differences were not statistically significant.
CONCLUSIONS CONCLUSIONS
Our study found a higher incidence of anticonvulsant discrepancies compared with previous studies. This quality improvement initiative identified the absence of a standardized process as the root cause for the high incidence of anticonvulsant discrepancies in pediatric patients with epilepsy at hospital admission.

Identifiants

pubmed: 34035684
doi: 10.5863/1551-6776-26.4.384
pmc: PMC8139569
doi:

Types de publication

Journal Article

Langues

eng

Pagination

384-394

Informations de copyright

Copyright. Pediatric Pharmacy Association. All rights reserved. For permissions, email: mhelms@pediatricpharmacy.org 2021.

Déclaration de conflit d'intérêts

Disclosures. The authors declare no conflicts or financial interest in any product or service mentioned in the manuscript, including grants, equipment, medications, employment, gifts, and honoraria. Katie Louiselle and Damon Pabst have full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Références

Res Social Adm Pharm. 2018 Jul;14(7):695-699
pubmed: 29239778
Arch Intern Med. 2005 Feb 28;165(4):424-9
pubmed: 15738372
J Child Neurol. 2013 Mar;28(3):314-20
pubmed: 22752478
Int J Clin Pharm. 2018 Feb;40(1):196-201
pubmed: 29248986
Can J Hosp Pharm. 2011 Jan;64(1):10-5
pubmed: 22479023
P T. 2018 Nov;43(11):676-684
pubmed: 30410283
Am J Health Syst Pharm. 2014 Sep 1;71(17):1469-79
pubmed: 25147171
Qual Saf Health Care. 2006 Dec;15 Suppl 1:i50-8
pubmed: 17142610
Hosp Pediatr. 2015 Aug;5(8):439-45
pubmed: 26231634
Pediatr Neurol. 2014 Nov;51(5):632-40
pubmed: 25193412
JAMA. 2001 Apr 25;285(16):2114-20
pubmed: 11311101
Acad Pediatr. 2009 Sep-Oct;9(5):360-365.e1
pubmed: 19640822

Auteurs

Classifications MeSH